Editing Streptomyces genome using target AID system fused with UGI‐degradation tag
Open Access
- 24 June 2024
- journal article
- research article
- Published by Wiley in Engineering in Life Sciences
- Vol. 24 (8) , e2400005
Abstract
The utilization of Streptomyces as a microbial chassis for developing innovative drugs and medicinal compounds showcases its capability to produce bioactive natural substances. Recent focus on the clustered regularly interspaced short palindromic repeat (CRISPR) technology highlights its potential in genome editing. However, applying CRISPR technology in certain microbial strains, particularly Streptomyces, encounters specific challenges. These challenges include achieving efficient gene expression and maintaining genetic stability, which are critical for successful genome editing. To overcome these obstacles, an innovative approach has been developed that combines several key elements: activation‐induced cytidine deaminase (AID), nuclease‐deficient cas9 variants (dCas9), and Petromyzon marinus cytidine deaminase 1 (PmCDA1). In this study, this novel strategy was employed to engineer a Streptomyces coelicolor strain. The target gene was actVA‐ORF4 (SCO5079), which is involved in actinorhodin production. The engineering process involved introducing a specific construct [pGM1190‐dcas9‐pmCDA‐UGI‐AAV‐actVA‐ORF4 (SCO5079)] to create a CrA10 mutant strain. The resulting CrA10 mutant strain did not produce actinorhodin. This outcome highlights the potential of this combined approach in the genetic manipulation of Streptomyces. The failure of the CrA10 mutant to produce actinorhodin conclusively demonstrates the success of gene editing at the targeted site, affirming the effectiveness of this method for precise genetic modifications in Streptomyces.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Science and Technology Research Partnership for Sustainable Development
This publication has 45 references indexed in Scilit:
- Insecticidal Endostemonines A–J Produced by Endophytic Streptomyces from Stemona sessilifoliaJournal of Agricultural and Food Chemistry, 2020
- Efficient editing DNA regions with high sequence identity in actinomycetal genomes by a CRISPR-Cas9 systemSynthetic and Systems Biotechnology, 2019
- Hygrocin C from marine-derived Streptomyces sp. SCSGAA 0027 inhibits biofilm formation in Bacillus amyloliquefaciens SCSGAB0082 isolated from South China Sea gorgonianApplied Microbiology and Biotechnology, 2017
- Bioactive metabolites produced by Streptomyces Cheonanensis VUK-A from Coringa mangrove sediments: isolation, structure elucidation and bioactivity3 Biotech, 2016
- Highly efficient editing of the actinorhodin polyketide chain length factor gene in Streptomyces coelicolor M145 using CRISPR/Cas9-CodA(sm) combined systemApplied Microbiology and Biotechnology, 2015
- Harnessing CRISPR–Cas systems for bacterial genome editingTrends in Microbiology, 2015
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Identification of the actinorhodin monomer and its related compound from a deletion mutant of the actVA-ORF4 gene of Streptomyces coelicolor A3(2)Bioorganic & Medicinal Chemistry Letters, 2012
- Introduction of DNA into Actinomycetes by bacterial conjugation from E. coli—An evaluation of various transfer systemsJournal of Biotechnology, 2005
- Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: Protein mimicry of DNACell, 1995